Diane C. Young
VP, Chief Medical Officer, Oncternal Therapeutics, Inc.
Companies
- Celldex TherapeuticsSVP, Chief Medical Officer Jul 8, 2019 to now1
- Oncternal Therapeutics, Inc.VP, Chief Medical Officer Jul 15, 2015 to Jul 17, 20182
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Celldex Therapeutics CLDX17,115 shares3$471.2K at $27.53Jun 11, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2024Exercised options 15,000 shares at $2.71 of Celldex Therapeutics3
- Jun 7, 2024Sold 45,000 shares at $35.26 of Celldex Therapeutics4
- Aug 17, 2022Exercised options 45,000 shares at $2.71 of Celldex Therapeutics5
- Aug 17, 2022Sold 19,000 shares at $37.30 of Celldex Therapeutics5
- Aug 17, 2022Exercised options 19,000 shares at $10.38 of Celldex Therapeutics5
- Nov 12, 2021Sold 4,600 shares at $42.94 of Celldex Therapeutics6
- Nov 12, 2021Exercised options 4,600 shares at $10.38 of Celldex Therapeutics6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 11, 2024
- 5SEC EDGARForm 4 filed Aug 19, 2022
- 6SEC EDGARForm 4 filed Nov 16, 2021